| Product Code: ETC10797226 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Pharmacogenomics Technology Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 South Korea Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 South Korea Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 South Korea Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 South Korea Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 South Korea Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 South Korea Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing adoption of personalized medicine in South Korea |
3.9.2 Growing awareness about the benefits of pharmacogenomics technology |
3.9.3 Government initiatives to promote precision medicine research and development |
4 South Korea Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenomics testing |
4.3.2 Limited availability of skilled professionals in the field of pharmacogenomics |
4.3.3 Regulatory challenges related to genetic testing and data privacy issues |
5 South Korea Pharmacogenomics Technology Market Trends |
6 South Korea Pharmacogenomics Technology Market, By Types |
6.1 South Korea Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 South Korea Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 South Korea Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 South Korea Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 South Korea Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 South Korea Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 South Korea Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 South Korea Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 South Korea Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 South Korea Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 South Korea Pharmacogenomics Technology Market Export to Major Countries |
7.2 South Korea Pharmacogenomics Technology Market Imports from Major Countries |
8 South Korea Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Number of clinical trials incorporating pharmacogenomics technology in South Korea |
8.2 Rate of adoption of pharmacogenomics testing in healthcare institutions |
8.3 Investment in research and development of pharmacogenomics technologies in South Korea |
8.4 Number of partnerships and collaborations between industry players and research institutions in the pharmacogenomics sector |
9 South Korea Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 South Korea Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 South Korea Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 South Korea Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 South Korea Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 South Korea Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 South Korea Pharmacogenomics Technology Market - Competitive Landscape |
10.1 South Korea Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 South Korea Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here